Eupraxia Pharmaceuticals (EPRX) Receivables - Other (2022 - 2025)
Eupraxia Pharmaceuticals' Receivables - Other came in at $688,219 for Q2 2026, up 411.3% from $134,607 a year earlier and up 3.8% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Receivables - Other (2022 - 2025) Analysis & Trends
At the end of FY2025, Eupraxia Pharmaceuticals' Receivables - Other was $674,226, up 194.6% from FY2024.
- Receivables - Other has increased in each of the last three years, with a three-year compound annual growth rate of 95.9% (FY2022 to FY2025).
- Going back by year, Receivables - Other was $228,872 in FY2024 (+20.1%), $190,612 in FY2023 (+112.5%) and $89,715 in FY2022.
- The Q2 2026 figure represents the highest quarterly Receivables - Other in data going back to Q4 2022.
- Year-over-year, Receivables - Other has increased for four consecutive quarters, with growth averaging 123.6% over the last seven quarters.
- The fastest year-over-year change in Receivables - Other over five years came in Q2 2026 (growth of 411.3%), and the weakest in Q2 2025 (a decline of 13.3%).
- Business Quant data shows EPRX's Receivables - Other at $663,235 (Q1 2026), $674,226 (Q4 2025) and $139,904 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 674,226.00 |
| Dec 31, 2024 | 228,872.00 |
| Dec 31, 2023 | 190,612.00 |
| Dec 31, 2022 | 89,715.00 |
API Access
Eupraxia Pharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();